BDTX Black Diamond Therapeutics | $3.56
-2.7% | 10/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 -> $16.00 | High | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 10/8/2024 |
UFPI UFP Industries | $135.00
+4.2% | 10/8/2024 | Upgraded by | Wedbush | - | Neutral -> Outperform | $120.00 -> $155.00 | High | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 10/8/2024 |
CVNA Carvana | $190.96
+6.2% | 10/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $150.00 -> $175.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 10/7/2024 |
SRRK Scholar Rock | $29.49
-14.0% | 10/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $27.00 -> $37.00 | N/A | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 10/7/2024 |
DPZ Domino's Pizza | $411.21
+0.3% | 10/4/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $510.00 -> $470.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 10/4/2024 |
LGIH LGI Homes | $111.06
+0.5% | 10/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $125.00 -> $125.00 | Medium | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 10/4/2024 |
|
RCUS Arcus Biosciences | $17.46
+0.9% | 10/3/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $30.00 -> $30.00 | High | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 10/3/2024 |
LRMR Larimar Therapeutics | $7.09
+9.4% | 10/3/2024 | Initiated by | Wedbush | Analyst L. Chico | Outperform | $22.00 | High | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 10/3/2024 |
SIMO Silicon Motion Technology | $60.19
0.0% | 10/2/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 10/2/2024 |
CATX Perspective Therapeutics | $13.17
+0.3% | 9/30/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy | | Low | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 9/30/2024 |
CYBR CyberArk Software | $282.41
+2.3% | 10/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $325.00 | High | View details for Wedbush rating of CyberArk Software (NASDAQ:CYBR) on 10/1/2024 |
IGMS IGM Biosciences | $14.55
+6.0% | 10/1/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $25.00 -> $22.00 | High | View details for Wedbush rating of IGM Biosciences (NASDAQ:IGMS) on 10/1/2024 |
DIN Dine Brands Global | $29.78
-2.3% | 10/1/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $34.00 -> $47.00 | High | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 10/1/2024 |
CATX Perspective Therapeutics | $13.17
+0.3% | 10/1/2024 | Initiated by | Wedbush | - | Outperform | $25.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 10/1/2024 |
INZY Inozyme Pharma | $5.25
+0.6% | 9/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 -> $15.00 | High | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 9/30/2024 |
CRM Salesforce | $291.57
+2.5% | 9/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $315.00 -> $325.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 9/27/2024 |
MU Micron Technology | $102.54
-0.4% | 9/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 -> $140.00 | High | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 9/26/2024 |
PLTR Palantir Technologies | $41.45
+6.6% | 9/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $38.00 -> $45.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 9/26/2024 |
SOUN SoundHound AI | $4.68
-1.3% | 9/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $9.00 -> $9.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 9/26/2024 |
ANAB AnaptysBio | $32.35
-2.0% | 9/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $42.00 -> $42.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 9/26/2024 |
VRNT Verint Systems | $23.98
+1.8% | 9/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $38.00 -> $38.00 | Low | View details for Wedbush rating of Verint Systems (NASDAQ:VRNT) on 9/26/2024 |
META Meta Platforms | $592.89
+1.4% | 9/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $600.00 -> $600.00 | Medium | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 9/26/2024 |
WD Walker & Dunlop | $111.66
+1.1% | 9/25/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $105.00 -> $110.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 9/25/2024 |
KBH KB Home | $81.10
+1.4% | 9/25/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $67.00 -> $75.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 9/25/2024 |
CFR Cullen/Frost Bankers | $113.43
+0.0% | 9/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $124.00 -> $123.00 | Low | View details for Wedbush rating of Cullen/Frost Bankers (NYSE:CFR) on 9/24/2024 |
WAL Western Alliance Bancorporation | $83.79
-0.3% | 9/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $105.00 | Low | View details for Wedbush rating of Western Alliance Bancorporation (NYSE:WAL) on 9/24/2024 |
BKU BankUnited | $34.88
-1.1% | 9/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $39.00 -> $40.00 | Low | View details for Wedbush rating of BankUnited (NYSE:BKU) on 9/24/2024 |
VLY Valley National Bancorp | $8.75
-1.0% | 9/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $9.00 -> $10.00 | Low | View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 9/24/2024 |
CVBF CVB Financial | $17.85
-0.6% | 9/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $21.00 -> $20.00 | Low | View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 9/24/2024 |
HAFC Hanmi Financial | $18.75
-0.6% | 9/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $22.00 -> $21.00 | Low | View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 9/24/2024 |
AX Axos Financial | $60.29
-1.1% | 9/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $80.00 -> $75.00 | Low | View details for Wedbush rating of Axos Financial (NYSE:AX) on 9/24/2024 |
TCBI Texas Capital Bancshares | $73.18
+1.3% | 9/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $70.00 -> $77.00 | Medium | View details for Wedbush rating of Texas Capital Bancshares (NASDAQ:TCBI) on 9/24/2024 |
PPBI Pacific Premier Bancorp | $24.52
+0.6% | 9/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $28.00 -> $27.00 | Low | View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 9/24/2024 |
SLM SLM | $22.84
-0.4% | 9/24/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $29.00 -> $26.00 | Low | View details for Wedbush rating of SLM (NASDAQ:SLM) on 9/24/2024 |
KEY KeyCorp | $16.73
-0.2% | 9/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $17.00 -> $18.00 | Low | View details for Wedbush rating of KeyCorp (NYSE:KEY) on 9/24/2024 |
MTB M&T Bank | $177.52
-0.2% | 9/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $208.00 -> $210.00 | Low | View details for Wedbush rating of M&T Bank (NYSE:MTB) on 9/24/2024 |
IDYA IDEAYA Biosciences | $31.06
+5.6% | 9/24/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $54.00 -> $52.00 | Medium | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/24/2024 |
TXRH Texas Roadhouse | $176.86
+0.8% | 9/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $190.00 -> $190.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 9/24/2024 |
PB Prosperity Bancshares | $70.33
-0.3% | 9/24/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $75.00 -> $90.00 | Medium | View details for Wedbush rating of Prosperity Bancshares (NYSE:PB) on 9/24/2024 |
RF Regions Financial | $22.74
-0.3% | 9/24/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $23.00 -> $28.00 | Medium | View details for Wedbush rating of Regions Financial (NYSE:RF) on 9/24/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
FHN First Horizon | $15.46
-1.2% | 9/24/2024 | Downgraded by | Wedbush | Analyst D. Chiaverini | Outperform -> Neutral | $20.00 -> $17.00 | Medium | View details for Wedbush rating of First Horizon (NYSE:FHN) on 9/24/2024 |
FCNCA First Citizens BancShares | $1,939.90
-0.3% | 9/24/2024 | Downgraded by | Wedbush | Analyst D. Chiaverini | Outperform -> Neutral | $2,450.00 -> $2,150.00 | High | View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 9/24/2024 |
CUBI Customers Bancorp | $44.80
-1.4% | 9/24/2024 | Downgraded by | Wedbush | Analyst D. Chiaverini | Outperform -> Neutral | $79.00 -> $53.00 | High | View details for Wedbush rating of Customers Bancorp (NYSE:CUBI) on 9/24/2024 |
CMA Comerica | $57.87
-0.7% | 9/24/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $52.00 -> $75.00 | Low | View details for Wedbush rating of Comerica (NYSE:CMA) on 9/24/2024 |
COLB Columbia Banking System | $25.55
0.0% | 9/24/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $28.00 -> $31.00 | Low | View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 9/24/2024 |
BANC Banc of California | $13.82
+1.2% | 9/24/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $14.00 -> $18.00 | Low | View details for Wedbush rating of Banc of California (NYSE:BANC) on 9/24/2024 |
BIIB Biogen | $182.30
-0.6% | 9/23/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $210.00 -> $205.00 | Medium | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 9/23/2024 |
CRBP Corbus Pharmaceuticals | $19.58
+3.1% | 9/20/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $85.00 -> $51.00 | High | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 9/20/2024 |
LEN Lennar | $181.21
-0.4% | 9/20/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $144.00 -> $144.00 | Medium | View details for Wedbush rating of Lennar (NYSE:LEN) on 9/20/2024 |
ACET Adicet Bio | $1.43
+1.4% | 9/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 9/20/2024 |
LTC LTC Properties | $35.69
-1.2% | 9/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $40.00 -> $40.00 | High | View details for Wedbush rating of LTC Properties (NYSE:LTC) on 9/20/2024 |
DRI Darden Restaurants | $159.13
-0.3% | 9/20/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $170.00 -> $200.00 | High | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 9/20/2024 |
PLTK Playtika | $7.59
-0.4% | 9/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.50 -> $11.50 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 9/19/2024 |
AZO AutoZone | $3,101.85
+1.6% | 9/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,200.00 -> $3,200.00 | High | View details for Wedbush rating of AutoZone (NYSE:AZO) on 9/19/2024 |
GEO The GEO Group | $13.75
+0.2% | 9/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 -> $17.00 | High | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 9/19/2024 |
CGEM Cullinan Therapeutics | $16.11
+0.4% | 9/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $36.00 -> $36.00 | Medium | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 9/18/2024 |
KMX CarMax | $72.13
-0.2% | 9/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $95.00 -> $95.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 9/17/2024 |
LBPH Longboard Pharmaceuticals | $33.63
+0.8% | 9/17/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $44.00 | High | View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 9/17/2024 |
Z Zillow Group | $62.26
+2.5% | 9/16/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $50.00 -> $80.00 | Low | View details for Wedbush rating of Zillow Group (NASDAQ:Z) on 9/16/2024 |
NUVL Nuvalent | $102.40
-0.9% | 9/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $99.00 -> $115.00 | High | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 9/16/2024 |
U Unity Software | $21.18
-0.1% | 9/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $21.00 -> $27.00 | Medium | View details for Wedbush rating of Unity Software (NYSE:U) on 9/16/2024 |
WING Wingstop | $403.52
+1.9% | 9/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $425.00 -> $440.00 | Medium | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 9/16/2024 |
ZG Zillow Group | $60.35
+2.5% | 9/16/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $50.00 -> $80.00 | High | View details for Wedbush rating of Zillow Group (NASDAQ:ZG) on 9/16/2024 |
RH RH | $322.08
-1.6% | 9/13/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $250.00 -> $310.00 | High | View details for Wedbush rating of RH (NYSE:RH) on 9/13/2024 |
CXW CoreCivic | $12.73
| 9/13/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $14.00 -> $14.00 | Medium | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 9/13/2024 |
TTD Trade Desk | $114.53
+2.4% | 9/12/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $110.00 -> $115.00 | Medium | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 9/12/2024 |
DBD Diebold Nixdorf | $44.03
+0.1% | 9/12/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform -> Outperform | $50.00 -> $50.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 9/12/2024 |
KBH KB Home | $81.10
+1.4% | 9/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $67.00 -> $67.00 | Medium | View details for Wedbush rating of KB Home (NYSE:KBH) on 9/12/2024 |
GLUE Monte Rosa Therapeutics | $5.00
-1.4% | 9/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 9/12/2024 |
NUVB Nuvation Bio | $2.23
+2.8% | 9/11/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | High | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 9/11/2024 |
RKT Rocket Companies | $17.56
+0.3% | 9/11/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $15.00 -> $18.00 | Medium | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 9/11/2024 |
WOOF Petco Health and Wellness | $5.77
+11.6% | 9/11/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | High | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 9/11/2024 |
ASO Academy Sports and Outdoors | $55.00
+0.3% | 9/11/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $65.00 -> $65.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 9/11/2024 |
LEN Lennar | $181.21
-0.4% | 9/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $144.00 -> $144.00 | Medium | View details for Wedbush rating of Lennar (NYSE:LEN) on 9/11/2024 |
GME GameStop | $20.65
-1.2% | 9/11/2024 | Target Lowered by | Wedbush | - | Underperform -> Underperform | $11.00 -> $10.00 | High | View details for Wedbush rating of GameStop (NYSE:GME) on 9/11/2024 |
ACET Adicet Bio | $1.43
+1.4% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 9/10/2024 |
PRGS Progress Software | $66.02
+0.3% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $68.00 -> $68.00 | Medium | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 9/10/2024 |
BDTX Black Diamond Therapeutics | $3.56
-2.7% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 -> $16.00 | High | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 9/10/2024 |
ANRO Alto Neuroscience | $11.25
+1.9% | 9/10/2024 | Reiterated by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $29.00 -> $29.00 | High | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 9/10/2024 |
VTR Ventas | $62.37
-0.4% | 9/10/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $64.00 -> $71.00 | Low | View details for Wedbush rating of Ventas (NYSE:VTR) on 9/10/2024 |
ORIC ORIC Pharmaceuticals | $9.49
-0.1% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 9/10/2024 |
YMAB Y-mAbs Therapeutics | $14.14
+0.7% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $23.00 -> $23.00 | Medium | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 9/10/2024 |
RBRK Rubrik | $34.62
+5.1% | 9/10/2024 | Target Lowered by | Wedbush | Analyst I. Koujalgi | Outperform -> Outperform | $50.00 -> $44.00 | High | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 9/10/2024 |
DRI Darden Restaurants | $159.13
-0.3% | 9/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $170.00 -> $170.00 | Medium | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 9/10/2024 |
TOST Toast | $28.81
+2.3% | 9/6/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Strong-Buy | | Low | View details for Wedbush rating of Toast (NYSE:TOST) on 9/6/2024 |
XNCR Xencor | $19.43
-0.3% | 9/9/2024 | Reiterated by | Wedbush | - | Outperform | $34.00 | High | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 9/9/2024 |
PLTR Palantir Technologies | $41.45
+6.6% | 9/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $38.00 -> $38.00 | High | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 9/9/2024 |
NUVL Nuvalent | $102.40
-0.9% | 9/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $99.00 -> $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 9/9/2024 |
AAPL Apple | $225.77
+1.8% | 9/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $285.00 -> $285.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 9/9/2024 |
LGIH LGI Homes | $111.06
+0.5% | 9/9/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Underperform -> Neutral | $97.00 -> $125.00 | High | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 9/9/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
ORKA Oruka Therapeutics | $27.51
+5.8% | 9/3/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy | | Low | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/3/2024 |
AI C3.ai | $24.45
+1.4% | 9/5/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $40.00 -> $30.00 | Low | View details for Wedbush rating of C3.ai (NYSE:AI) on 9/5/2024 |
GOOGL Alphabet | $164.38
+0.9% | 9/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $205.00 -> $205.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 9/5/2024 |
ASO Academy Sports and Outdoors | $55.00
+0.3% | 9/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $65.00 -> $65.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 9/5/2024 |
DKS DICK'S Sporting Goods | $205.58
-0.3% | 9/5/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 9/5/2024 |
BZH Beazer Homes USA | $32.24
+0.8% | 9/5/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $41.00 -> $45.00 | Low | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 9/5/2024 |
ORKA Oruka Therapeutics | $27.51
+5.8% | 9/4/2024 | Initiated by | Wedbush | - | Outperform | $40.00 | Low | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/4/2024 |
ZS Zscaler | $176.93
+2.8% | 9/4/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $260.00 -> $220.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
SYRE Spyre Therapeutics | $27.88
+1.4% | 9/4/2024 | Initiated by | Wedbush | - | Outperform | $45.00 | Low | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 9/4/2024 |
TPX Tempur Sealy International | $52.00
-0.5% | 9/4/2024 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $52.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 9/4/2024 |
PRPL Purple Innovation | $0.94
+3.3% | 9/4/2024 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $1.75 -> $1.10 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 9/4/2024 |
COGT Cogent Biosciences | $10.85
+1.0% | 9/3/2024 | Reiterated by | Wedbush | - | Neutral | $10.00 -> $11.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 9/3/2024 |
CNK Cinemark | $26.92
-0.2% | 9/3/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $28.00 -> $31.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 9/3/2024 |
IMAX IMAX | $19.41
-1.4% | 9/3/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $26.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 9/3/2024 |
WLDN Willdan Group | $43.59
+0.2% | 9/3/2024 | Initiated by | Wedbush | Analyst J. Mccanless | Outperform | $35.00 -> $51.00 | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 9/3/2024 |
ANRO Alto Neuroscience | $11.25
+1.9% | 9/3/2024 | Initiated by | Wedbush | Analyst L. Chico | Outperform | $29.00 | Low | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 9/3/2024 |
ARTV Artiva Biotherapeutics | $14.86
+2.4% | 8/30/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $18.00 | N/A | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 8/30/2024 |
BBY Best Buy | $98.33
+0.5% | 8/30/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $85.00 -> $95.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 8/30/2024 |
NVDA NVIDIA | $132.89
+4.0% | 8/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $138.00 -> $138.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 8/29/2024 |
CHWY Chewy | $29.51
+5.3% | 8/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $35.00 -> $35.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 8/29/2024 |
AFRM Affirm | $41.15
+6.6% | 8/29/2024 | Target Raised by | Wedbush | - | Underperform -> Underperform | $20.00 -> $25.00 | Low | View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 8/29/2024 |
CRM Salesforce | $291.57
+2.5% | 8/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 -> $315.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 8/29/2024 |
CMG Chipotle Mexican Grill | $57.99
+2.2% | 8/29/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $58.00 -> $58.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 8/29/2024 |
BJRI BJ's Restaurants | $32.49
-0.7% | 8/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $43.00 -> $43.00 | Low | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 8/29/2024 |
SWTX SpringWorks Therapeutics | $32.41
+0.4% | 8/28/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 -> $77.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 8/28/2024 |
LULU Lululemon Athletica | $276.59
+1.5% | 8/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $400.00 -> $324.00 | Low | View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 8/28/2024 |
DKS DICK'S Sporting Goods | $205.58
-0.3% | 8/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $230.00 -> $250.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 8/28/2024 |
TOL Toll Brothers | $151.17
+0.5% | 8/27/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $120.00 -> $148.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 8/27/2024 |
NTAP NetApp | $126.55
+2.2% | 8/26/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $120.00 -> $120.00 | Low | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 8/26/2024 |
PSTG Pure Storage | $52.51
+2.3% | 8/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $80.00 -> $80.00 | Low | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 8/26/2024 |
S SentinelOne | $24.65
+6.2% | 8/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $20.00 -> $30.00 | Low | View details for Wedbush rating of SentinelOne (NYSE:S) on 8/26/2024 |
VRNS Varonis Systems | $56.55
+1.9% | 8/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $67.00 -> $67.00 | Low | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 8/26/2024 |
AAP Advance Auto Parts | $38.85
-0.6% | 8/23/2024 | Reiterated by | Wedbush | - | Neutral | $65.00 -> $55.00 | N/A | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 8/23/2024 |
NVDA NVIDIA | $132.89
+4.0% | 8/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $120.00 -> $138.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 8/23/2024 |
WSM Williams-Sonoma | $149.55
0.0% | 8/23/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $175.00 -> $150.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 8/23/2024 |
CAVA CAVA Group | $131.97
+4.7% | 8/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $100.00 -> $120.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 8/23/2024 |
PZZA Papa Johns International | $49.05
-0.6% | 8/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $51.00 -> $51.00 | Low | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 8/23/2024 |
NUVB Nuvation Bio | $2.23
+2.8% | 8/22/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 8/22/2024 |
NUVL Nuvalent | $102.40
-0.9% | 8/22/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 8/22/2024 |
SNOW Snowflake | $113.51
-0.3% | 8/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $210.00 -> $140.00 | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 8/22/2024 |
TOL Toll Brothers | $151.17
+0.5% | 8/21/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $120.00 -> $120.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 8/21/2024 |
TTWO Take-Two Interactive Software | $152.94
+0.5% | 8/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $190.00 -> $190.00 | Low | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 8/21/2024 |
LOW Lowe's Companies | $273.27
+1.8% | 8/21/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | Low | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 8/21/2024 |
CVNA Carvana | $190.96
+6.2% | 8/19/2024 | Upgraded by | Wedbush | - | Neutral | $120.00 -> $150.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 8/19/2024 |
O Realty Income | $61.52
-0.2% | 8/19/2024 | Initiated by | Wedbush | Analyst J. Kornreich | Neutral | $64.00 | Low | View details for Wedbush rating of Realty Income (NYSE:O) on 8/19/2024 |
EPRT Essential Properties Realty Trust | $32.74
+0.5% | 8/19/2024 | Initiated by | Wedbush | Analyst J. Kornreich | Outperform | $34.00 | Low | View details for Wedbush rating of Essential Properties Realty Trust (NYSE:EPRT) on 8/19/2024 |
BNL Broadstone Net Lease | $18.20
+0.6% | 8/19/2024 | Initiated by | Wedbush | Analyst J. Kornreich | Outperform | $20.00 | Low | View details for Wedbush rating of Broadstone Net Lease (NYSE:BNL) on 8/19/2024 |
NTST NETSTREIT | $15.44
-0.5% | 8/19/2024 | Initiated by | Wedbush | Analyst J. Kornreich | Neutral | $17.00 | Low | View details for Wedbush rating of NETSTREIT (NYSE:NTST) on 8/19/2024 |
TRNO Terreno Realty | $64.71
-0.7% | 8/16/2024 | Reiterated by | Wedbush | - | Neutral | $57.00 -> $70.00 | Low | View details for Wedbush rating of Terreno Realty (NYSE:TRNO) on 8/16/2024 |
NICE NICE | $166.65
-2.2% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 -> $250.00 | Low | View details for Wedbush rating of NICE (NASDAQ:NICE) on 8/16/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
KMX CarMax | $72.13
-0.2% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $95.00 -> $95.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 8/16/2024 |
PHM PulteGroup | $140.16
+0.5% | 8/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 -> $115.00 | Low | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 8/16/2024 |
EWTX Edgewise Therapeutics | $28.49
+3.2% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $31.00 -> $31.00 | Low | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 8/16/2024 |
RITM Rithm Capital | $10.66
+0.8% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 -> $13.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 8/16/2024 |
PL Planet Labs PBC | $2.14
-5.3% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | Low | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 8/16/2024 |
PANW Palo Alto Networks | $355.13
+5.1% | 8/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $375.00 -> $375.00 | Low | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 8/16/2024 |
XOS XOS | $4.55
-0.4% | 8/15/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $15.00 -> $12.00 | Low | View details for Wedbush rating of XOS (NASDAQ:XOS) on 8/15/2024 |
REKR Rekor Systems | $1.12
-1.8% | 8/15/2024 | Reiterated by | Wedbush | - | Outperform | | Low | View details for Wedbush rating of Rekor Systems (NASDAQ:REKR) on 8/15/2024 |
EAT Brinker International | $84.52
+2.5% | 8/15/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $68.00 -> $68.00 | Low | View details for Wedbush rating of Brinker International (NYSE:EAT) on 8/15/2024 |
IGMS IGM Biosciences | $14.55
+6.0% | 8/14/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $25.00 | Low | View details for Wedbush rating of IGM Biosciences (NASDAQ:IGMS) on 8/14/2024 |
SDHC Smith Douglas Homes | $38.32
+4.2% | 8/14/2024 | Reiterated by | Wedbush | - | Neutral | $20.00 | Low | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 8/14/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 8/14/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $40.00 -> $48.00 | Low | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/14/2024 |
TOL Toll Brothers | $151.17
+0.5% | 8/14/2024 | Reiterated by | Wedbush | - | Neutral | $120.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 8/14/2024 |
CMG Chipotle Mexican Grill | $57.99
+2.2% | 8/14/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $54.00 -> $58.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 8/14/2024 |
ACET Adicet Bio | $1.43
+1.4% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 8/13/2024 |
CMRX Chimerix | $0.87
-5.5% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | Low | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 8/13/2024 |
SE SEA | $95.35
+0.2% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $76.00 -> $84.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 8/13/2024 |
FENC Fennec Pharmaceuticals | $4.51
-1.3% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 -> $14.00 | Low | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 8/13/2024 |
SBUX Starbucks | $96.21
+0.1% | 8/13/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 -> $80.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 8/13/2024 |
APRE Aprea Therapeutics | $2.60
-0.8% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 8/13/2024 |
RUM Rumble | $5.36
-0.2% | 8/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral -> Neutral | $8.00 -> $8.00 | Low | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 8/13/2024 |
IMNM Immunome | $12.90
+3.6% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $33.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 8/13/2024 |
GOSS Gossamer Bio | $1.02
-2.9% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $4.00 -> $4.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 8/13/2024 |
ATXS Astria Therapeutics | $11.21
-3.9% | 8/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 -> $22.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 8/13/2024 |
KEY KeyCorp | $16.73
-0.2% | 8/13/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $16.00 -> $17.00 | Low | View details for Wedbush rating of KeyCorp (NYSE:KEY) on 8/13/2024 |
DDI DoubleDown Interactive | $14.65
-3.4% | 8/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $14.75 -> $16.25 | Low | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 8/13/2024 |
ARTV Artiva Biotherapeutics | $14.86
+2.4% | 8/13/2024 | Initiated by | Wedbush | Analyst D. Nierengarten | Outperform | $18.00 | Low | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 8/13/2024 |
TCRX TScan Therapeutics | $5.59
+1.6% | 8/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 8/12/2024 |
ORIC ORIC Pharmaceuticals | $9.49
-0.1% | 8/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | Low | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 8/12/2024 |
YMAB Y-mAbs Therapeutics | $14.14
+0.7% | 8/12/2024 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 8/12/2024 |
RC Ready Capital | $7.14
| 8/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $9.00 -> $9.00 | Low | View details for Wedbush rating of Ready Capital (NYSE:RC) on 8/12/2024 |
PGY Pagaya Technologies | $10.13
-0.4% | 8/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.00 -> $13.00 | Low | View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 8/12/2024 |
ZNTL Zentalis Pharmaceuticals | $3.04
-2.3% | 8/12/2024 | Upgraded by | Wedbush | Analyst R. Driscoll | Underperform -> Neutral | $4.00 | Low | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 8/12/2024 |
HEAR Turtle Beach | $14.97
-1.7% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 8/9/2024 |
SOUN SoundHound AI | $4.68
-1.3% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $9.00 -> $9.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 8/9/2024 |
CRWD CrowdStrike | $293.01
+2.1% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 -> $315.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 8/9/2024 |
DDOG Datadog | $123.72
+1.1% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $155.00 -> $155.00 | Low | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 8/9/2024 |
U Unity Software | $21.18
-0.1% | 8/9/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $33.50 -> $21.00 | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 8/9/2024 |
CYBR CyberArk Software | $282.41
+2.3% | 8/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $285.00 -> $300.00 | Low | View details for Wedbush rating of CyberArk Software (NASDAQ:CYBR) on 8/9/2024 |
DNTH Dianthus Therapeutics | $27.99
+5.7% | 8/9/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $38.00 -> $36.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 8/9/2024 |
RCUS Arcus Biosciences | $17.46
+0.9% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $30.00 -> $30.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 8/9/2024 |
XENE Xenon Pharmaceuticals | $41.02
+1.1% | 8/9/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $49.00 | Low | View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/9/2024 |
WD Walker & Dunlop | $111.66
+1.1% | 8/9/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $95.00 -> $105.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 8/9/2024 |
MFA MFA Financial | $12.23
+1.7% | 8/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $14.00 | Low | View details for Wedbush rating of MFA Financial (NYSE:MFA) on 8/9/2024 |
GHLD Guild | $16.12
+0.6% | 8/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $17.00 -> $19.00 | Low | View details for Wedbush rating of Guild (NYSE:GHLD) on 8/9/2024 |
BUR Burford Capital | $12.95
-0.6% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $18.00 -> $18.00 | Low | View details for Wedbush rating of Burford Capital (NYSE:BUR) on 8/9/2024 |
AAP Advance Auto Parts | $38.85
-0.6% | 8/9/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $65.00 -> $65.00 | Low | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 8/9/2024 |
APLS Apellis Pharmaceuticals | $27.40
-0.2% | 8/9/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $38.00 -> $41.00 | Low | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 8/9/2024 |
IRON Disc Medicine | $47.90
+1.2% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $57.00 -> $57.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 8/9/2024 |
KURA Kura Oncology | $18.16
+1.5% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 -> $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 8/9/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
TTD Trade Desk | $114.53
+2.4% | 8/9/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 8/9/2024 |
EXPE Expedia Group | $151.95
+0.6% | 8/9/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $125.00 -> $130.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 8/9/2024 |
LEGH Legacy Housing | $26.15
-0.2% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $29.00 -> $29.00 | Low | View details for Wedbush rating of Legacy Housing (NASDAQ:LEGH) on 8/9/2024 |
UAA Under Armour | $8.50
-0.1% | 8/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $8.00 -> $8.50 | Low | View details for Wedbush rating of Under Armour (NYSE:UAA) on 8/9/2024 |
PZZA Papa Johns International | $49.05
-0.6% | 8/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $51.00 -> $51.00 | Low | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 8/9/2024 |
CGEM Cullinan Therapeutics | $16.11
+0.4% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $36.00 -> $36.00 | Low | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 8/8/2024 |
FHTX Foghorn Therapeutics | $7.60
-2.3% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 -> $13.00 | Low | View details for Wedbush rating of Foghorn Therapeutics (NASDAQ:FHTX) on 8/8/2024 |
PRME Prime Medicine | $3.78
+3.6% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 8/8/2024 |
GERN Geron | $4.27
+2.9% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 8/8/2024 |
SRRK Scholar Rock | $29.49
-14.0% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 8/8/2024 |
ITOS iTeos Therapeutics | $9.43
-3.8% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform | $21.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 8/8/2024 |
NUVL Nuvalent | $102.40
-0.9% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform | $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 8/8/2024 |
APP AppLovin | $143.51
+2.5% | 8/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $100.00 -> $90.00 | Low | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 8/8/2024 |
DT Dynatrace | $53.26
-0.3% | 8/8/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $55.00 -> $55.00 | Low | View details for Wedbush rating of Dynatrace (NYSE:DT) on 8/8/2024 |
Z Zillow Group | $62.26
+2.5% | 8/8/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $50.00 -> $50.00 | Low | View details for Wedbush rating of Zillow Group (NASDAQ:Z) on 8/8/2024 |
TYRA Tyra Biosciences | $21.64
+3.8% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 -> $28.00 | Low | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 8/8/2024 |
RVMD Revolution Medicines | $49.77
+5.1% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $59.00 -> $59.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 8/8/2024 |
JANX Janux Therapeutics | $44.93
+1.8% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $74.00 -> $74.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 8/8/2024 |
GBIO Generation Bio | $2.32
+0.4% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | Low | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 8/8/2024 |
TNGX Tango Therapeutics | $6.89
-1.4% | 8/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 8/8/2024 |
CXW CoreCivic | $12.73
| 8/8/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $14.00 -> $14.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 8/8/2024 |
UMH UMH Properties | $18.64
+0.1% | 8/8/2024 | Target Raised by | Wedbush | Analyst R. Anderson | Neutral -> Neutral | $17.00 -> $20.00 | Low | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 8/8/2024 |
PLTK Playtika | $7.59
-0.4% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.50 -> $11.50 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 8/8/2024 |
ALIT Alight | $7.14
-0.8% | 8/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 8/8/2024 |
LYFT Lyft | $12.44
-0.6% | 8/8/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $19.00 -> $12.00 | Low | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 8/8/2024 |
DBD Diebold Nixdorf | $44.03
+0.1% | 8/8/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform -> Outperform | $50.00 -> $50.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 8/8/2024 |
RMBL RumbleOn | $4.87
+0.4% | 8/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Wedbush rating of RumbleOn (NASDAQ:RMBL) on 8/8/2024 |
CHWY Chewy | $29.51
+5.3% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $35.00 -> $35.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 8/8/2024 |
BROS Dutch Bros | $31.77
+0.4% | 8/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $45.00 -> $45.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 8/8/2024 |
DIN Dine Brands Global | $29.78
-2.3% | 8/8/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $37.00 -> $34.00 | Low | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 8/8/2024 |
GTHX G1 Therapeutics | $7.15
| 8/7/2024 | Downgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy -> Hold | | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 8/7/2024 |
SWTX SpringWorks Therapeutics | $32.41
+0.4% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 8/7/2024 |
SHOP Shopify | $82.58
+2.1% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral | $68.00 -> $72.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 8/7/2024 |
GFS GlobalFoundries | $39.53
-0.5% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $65.00 -> $65.00 | Low | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 8/7/2024 |
ABNB Airbnb | $132.50
+1.7% | 8/7/2024 | Target Lowered by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $165.00 -> $135.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 8/7/2024 |
CART Maplebear | $44.00
+4.9% | 8/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $35.00 -> $38.00 | Low | View details for Wedbush rating of Maplebear (NASDAQ:CART) on 8/7/2024 |
TPX Tempur Sealy International | $52.00
-0.5% | 8/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $55.00 -> $52.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 8/7/2024 |
TRIP Tripadvisor | $14.41
+0.3% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 -> $21.00 | Low | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 8/7/2024 |
UPST Upstart | $42.89
+4.6% | 8/7/2024 | Reiterated by | Wedbush | - | Underperform -> Underperform | $10.00 -> $10.00 | Low | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 8/7/2024 |
UWMC UWM | $7.33
-0.5% | 8/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $7.00 -> $8.50 | Low | View details for Wedbush rating of UWM (NYSE:UWMC) on 8/7/2024 |
SKY Skyline Champion | $94.37
+1.3% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $64.00 -> $64.00 | Low | View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 8/7/2024 |
SHOO Steven Madden | $47.08
-0.1% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $41.00 -> $41.00 | Low | View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 8/7/2024 |
RVLV Revolve Group | $24.15
+3.0% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $19.00 -> $19.00 | Low | View details for Wedbush rating of Revolve Group (NYSE:RVLV) on 8/7/2024 |
REAL RealReal | $3.34
+3.4% | 8/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $4.50 -> $4.00 | Low | View details for Wedbush rating of RealReal (NASDAQ:REAL) on 8/7/2024 |
IDYA IDEAYA Biosciences | $31.06
+5.6% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $54.00 -> $54.00 | Low | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/7/2024 |
CMPX Compass Therapeutics | $1.73
-10.8% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 -> $8.00 | Low | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 8/7/2024 |
BDTX Black Diamond Therapeutics | $3.56
-2.7% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 -> $16.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 8/7/2024 |
OMGA Omega Therapeutics | $1.07
| 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $12.00 -> $12.00 | Low | View details for Wedbush rating of Omega Therapeutics (NASDAQ:OMGA) on 8/7/2024 |
RIVN Rivian Automotive | $10.47
-0.2% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | Low | View details for Wedbush rating of Rivian Automotive (NASDAQ:RIVN) on 8/7/2024 |
GPRO GoPro | $1.30
-0.8% | 8/7/2024 | Target Lowered by | Wedbush | Analyst A. Reese | Neutral -> Neutral | $2.00 -> $1.50 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 8/7/2024 |
QLYS Qualys | $122.66
+1.3% | 8/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $190.00 -> $160.00 | Low | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 8/7/2024 |
RDFN Redfin | $10.26
-0.6% | 8/7/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $8.00 -> $8.00 | Low | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 8/7/2024 |
FTNT Fortinet | $77.78
+0.4% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $78.00 -> $78.00 | Low | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 8/7/2024 |
VYGR Voyager Therapeutics | $7.08
+4.3% | 8/7/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $8.00 -> $7.00 | Low | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 8/7/2024 |
GEO The GEO Group | $13.75
+0.2% | 8/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $19.00 -> $19.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 8/7/2024 |
JACK Jack in the Box | $43.98
+0.5% | 8/7/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $68.00 -> $60.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 8/7/2024 |
BLDR Builders FirstSource | $193.48
+0.7% | 8/6/2024 | Reiterated by | Wedbush | - | Outperform | $175.00 | Low | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 8/6/2024 |
INZY Inozyme Pharma | $5.25
+0.6% | 8/6/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 8/6/2024 |
COGT Cogent Biosciences | $10.85
+1.0% | 8/6/2024 | Reiterated by | Wedbush | - | Neutral | $10.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 8/6/2024 |
ELEV Elevation Oncology | $0.52
-3.7% | 8/6/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 8/6/2024 |
